genomics | Benzinga benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Share:
Ark Funds hosted an investor webinar Tuesday, sharing ideas on several industries and portfolio components, including a discussion on some names in the genomics space.
Ark Funds On Genomics: Ark Funds is well-known for its bullish thesis on the genomics market. The company has the Ark Genomic Revolution ETF (BATS: ARKG), an ETF devoted to the growth of the segment.
Exact Sciences (NASDAQ: EXAS) was highlighted by Ark Funds analyst Simon Barnett.
The company has made a series of acquisitions that could help the company’s position in the market, he said.
“Incorporating it all together, Exact can broaden out their portfolio [and] determine market share.”